查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197857

OPEP 設備市場 - 增長、趨勢、COVID-19 影響和預測 (2023-28)

Oscillating Positive Expiratory Pressure (OPEP) Devices Market - Growth, Trends, and Forecasts (2023-28)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，歐佩普（OPEP）設備市場預測的年復合增長率提高了5.3%。

因為疫情的爆發，多模式慢性肺病患者的市場受到了影響。 2021 年 10 月，ERJ 發表了一項描述性單項研究，有呼吸系統疾病史的患者比例、嚴重的 COVID-19 樣風和呼吸系統疾病史患者的死亡率增加。 同樣，國家生物技術信息中心 (NCBI) 於 2021 年 7 月進行的一項描述性單項研究在 COVID-19 慢性呼吸道疾病患者中很常見。 大流行早期呼吸道疾病病例增加了推進和振動常壓呼吸設備的需求，用於清除呼吸道疾病患者的肺部粘液。

起初，對OPEP設備的需求激增，但疫情結束後，需求急劇下降。

然而，肺炎和哮喘等呼吸系統疾病患者數量增加，OPEP設備市場在預測期內持續增長。

例如，NCBI 在 2021 年 6 月的 Expressive Single Study，慢性呼吸道疾病對國家、地區和全球疾病有嚴重影響。 根據該研究報告，發病率和死亡率的發生率較低，發病率中等偏高。 同樣，Nezu Lung India 在 2021 年 12 月發布的一份初步報告中指出，到 2021 年，印度男性和女性的慢性阻塞性肺病 (COPD) 患病率將達到 11.4%。 同樣，2021年版的禰豆子的ERS，2020年約有36,580,965名COPD患者，Mordor Intelligence分析預測，2050年約有49,453,852名COPD患者。

COPD發病率高的理髮創新設備及科研人員晉升。 例如，NCBI 於 2021 年 1 月發表了第二項研究，全球 COPD 病例呈上升趨勢，並引入了氣管內窺鏡等新的先進設備和新的手術程序。 因此，預測的呼吸系統疾病高發病率的積極進展將推動對OPEP設備的需求，市場增長將隨之而來。

此外，OPEP設備相關技術進步，驅動市場持續增長。 例如，2021 年 10 月 BMC Pulmonary Medicine 的一項單學期研究表明，可重複使用的 OPEP 設備現在需要定期清潔和消毒，從而防止隱藏的病原微生物。 然而，遵守呼吸設備清潔措施通常是關鍵。 出於這個原因，在初級 OPEP 設施原型 UL-OPEP 開發之後，出現了低病原體感染的趨勢。 種子技術進步並創造了新的市場機會，吸引了許多新進入者，並促進了增長。

另一方面，由於熟練專業人員的短期短缺，預測期內的市場增長。

OPEP設備市場趨勢

預測期內 COPD 區域的當前最大增長

哮喘是影響全世界兒童的最常見的慢性呼吸道疾病。 哮喘是一種影響肺部呼吸道的慢性（長期）疾病。 氣道是輸送空氣的肺道。 哮喘患者合併氣胸和氣道收縮。 防止爬行呼出空氣分隔的呼吸道。 COPD 是一組肺部疾病，會導致呼吸困難並隨時間惡化。 慢性阻塞性肺疾病在全球範圍內的高發病率是推動該地區增長的主要因素之一。

例如，ERJ Open Research 2022年8月出版第一版，ISAAC問卷調查，全球11-16歲兒童坐骨性支氣管哮喘發病率：13.1%。 我在這。 據報導，全球嬰兒哮喘患病率為10.2%。 同樣，Nezuo ScienceDirect，第一期出版於 2022 年 1 月，2021 年 SAT-Arabo 的哮喘發病率為 14.2%。

此外，日本疾病預防控制中心2022年7月發布的一份綜合報告顯示，2021年中國慢性阻塞性肺疾病超標率為5.6%。 5-29 歲人群 COPD 患病率中位數為 0.1%-0.9%，到 2021 年 30-30 歲人群將增加 1.6%-28.3%。 對OPEP設備的需求不斷增加，細分市場增長也被看好。

北美當期最長增速

在當前調查期間，以 Keiji Kitami 為首的 OPEP 設備市場。 該物種的增長是由於呼吸系統疾病病例增加和研究活動增加等因素造成的。 例如，在 2021 年 6 月的加拿大哮喘協會初步報告中，超過 850,000 名 14 歲以下兒童患有哮喘病，這是 14 歲以下兒童中最常見的慢性疾病，也是住院治療的主要原因。 同樣，Nezuko CMAJ Group 於 2021 年 5 月發表，哮喘是兒童最常見的慢性疾病，在加拿大的患病率為 15.0% 至 25.0%。

主要產品發布、市場參與者和製造商高度集中、主要參與者之間的採購合作以及美國呼吸系統疾病病例的增加是該國OPEP設備市場增長的驅動因素。 一項成就。 比如2022年8月發表的NCBI研究，在美國，每年的肺炎發病率為每10,000名成年人24.8例，而且每年的增長率還在上升。

OPEP設備市場競爭分析

全球 OPEP 設備市場競爭激烈。 Competitiveness Bureau 與市場上少數知名公司的綜合分析，例如 AirPhysio、D-R Burton Healthcare、Medica Holdings, LLC、Monaghan Medical Corporation、PARI GmbH 等知名公司。 Cegla GmbH &Co.KG 和 Smiths Medical, Inc.

其他地方

  • Excel 的正式市場預測 (ME) 表
  • 三元分析支持

內容

第一章介紹

  • 研究度假村市場的定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動力
    • 全球慢性呼吸道疾病增加
    • 牢不可破的技術進步
  • 市場因素
    • 缺乏熟練的專業人員
  • 特定於波浪的五力分析
    • 新人威脅
    • 買家/消費者關係能力
    • 商業議價能力
    • 替代威脅
    • 競爭公司之間的競爭

第五章市場細分（基礎市場規模：億元）

  • 安排產品類型
    • 面對面的 PEP 設備
    • 喉部 PEP 設備
    • 瓶型PEP裝置
  • 捨入說明
    • 慢性阻塞性肺病
    • 脊膜炎
    • 囊性纖維化
    • 其他
  • 最終用途
    • 日本診所
    • 專注於門診手術
    • 其他
  • 安吉區
    • 北方美女
      • 美國
      • 金代
      • 木齋閣
    • 潿洲島
      • 出國
      • 英國
      • 北谷 <李>
      • 西方毒牙
      • 其他西部地區
    • 阿泰吉區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞洲太極地區
    • 世界其他地區 (ROW)

第六章競爭局

  • 關於公司的信息
    • AirPhysio
    • Smiths Medical
    • D-R Burton Healthcare
    • Medica Holdings, LLC
    • Monaghan Medical Corporation
    • PARI GmbH
    • R. Cegla GmbH & Co. KG

第7章 市場機會今後動向

簡介目錄
Product Code: 69705

The oscillating positive expiratory pressure (OPEP) devices market is expected to register a CAGR of 5.3% over the forecast period.

The increased number of cases of chronic pulmonary diseases with the outbreak of the pandemic has impacted the market. According to a study published by the ERJ in October 2021, patients with prior influenza were at higher risk of developing severe COVID-19 and had a higher mortality rate than patients without a history of respiratory illness. Similarly, per a study published by the National Center for Biotechnology Information (NCBI) in July 2021, chronic respiratory diseases were common among patients with COVID-19. Increasing cases of respiratory diseases in the initial days of the pandemic propelled the demand for oscillating positive expiratory pressure devices as it is used to clear mucus from the lungs of individuals with respiratory illnesses.

Although there was a sharp rise in demand for OPEP devices initially, it has now reduced greatly now that the pandemic has ended.

However, the OPEP devices market is expected to maintain growth over the forecast period owing to growing cases of other respiratory diseases such as pneumonia and asthma.

For instance, according to a study published by the NCBI in June 2021, chronic respiratory diseases contribute significantly to the national, regional, and global burden of disease. The study also reported that morbidity and mortality from such conditions are estimated to be high in low- and middle-income countries. Similarly, as per the report published by Lung India in December 2021, the prevalence rate of chronic obstructive pulmonary disease (COPD) among males and females was 11.4% in India in 2021. Similarly, as per the ERS journal of 2021, it was estimated that around 36,580,965 Europeans suffered from COPD in 2020 and as per Mordor Intelligence analysis around 49,453,852 Europeans were expected to suffer from COPD in 2050.

Owing to such a high prevalence of COPD the researchers are also focusing on developing innovative and new devices for advanced treatment. For instance, as per another study published by the NCBI in January 2021, due to the increasing cases of COPD across the globe, the researchers were focusing on developing new advanced devices and novel surgical and bronchoscopic procedures. Therefore, such positive advancements and a high prevalence of respiratory diseases are anticipated to propel the demand for OPEP devices, thereby surging market growth.

Furthermore, the technological advancements related to OPEP devices are also pushing market growth. For instance, as per a study published by BMC Pulmonary Medicine in October 2021, currently, reusable OPEP devices are available that require regular cleaning and disinfection to prevent harboring of potentially pathogenic organisms. However, adherence to cleaning regimens for respiratory devices is often critical. Therefore, a prototype single-use OPEP device - "UL-OPEP" was developed to mitigate the risk of pathogen contamination. Such technological advancements and innovations may create opportunities for the market, which in turn may encourage many new players to enter the market and drive growth.

On the other hand, a lack of skilled professionals is likely to hinder the market growth over the forecast period.

Oscillating Positive Expiratory Pressure Devices Market Trends

COPD and Asthma Segment is Expected to Witness Largest Growth Over the Forecast Period

Asthma is the most common chronic respiratory disease affecting children globally. Asthma is a chronic (long-term) condition that affects the airways in the lungs. The airways are the tubes that carry air in and out of your lungs. The airways of asthma patients can sometimes become inflamed and narrow. This makes it difficult for air to flow out of the airways when exhaling. COPD is a group of lung diseases that make breathing difficult and worsen over time. The high prevalence of asthma and COPD across the globe is one of the major factors propelling the segment's growth.

For instance, per the journal published by the ERJ Open Research in August 2022, a study based on the ISAAC questionnaire reported a prevalence of bronchial asthma of 13.1% in children aged 11 to 16 years globally. It also reported that, globally, the prevalence of asthma in children was 10.2%. Similarly, as per a journal published by ScienceDirect in January 2022, the overall prevalence of asthma in Saudi Arabia was 14.2% in 2021.

Furthermore, per a report published by the CDC in July 2022, the overall prevalence rate of COPD in the United States in 2021 was more than 5.6%. The prevalence of COPD among individuals aged 5 to 29 years was found to range from 0.1% to 0.9%, increasing to 1.6% to 28.3% in the population aged 30 years in 2021. Such instances indicate that the demand for OPEP devices is anticipated to increase, propelling segment growth.

North America is Expected to Witness Largest Growth Over the Forecast Period

North America is expected to dominate the overall OPEP devices market over the forecast period. The growth is due to factors such as increasing cases of pediatric respiratory diseases and increasing research work. For instance, as per a report published by Asthma Canada in June 2021, more than 850,000 children under the age of 14 had asthma, thereby making it the most common chronic disease among children and the leading cause of both school absenteeism and hospitalization in Canada. Similarly, per a journal published by the CMAJ Group in May 2021, asthma is the most common chronic disease in children, with a prevalence of 15.0% to 25.0% in Canada.

Key product launches, high concentration of market players or manufacturer's presence, acquisition and partnerships among major players, and increasing cases of respiratory diseases in the United States are some of the factors driving the growth of the OPEP devices market in the country. For instance, as per an NCBI study published in August 2022, in the United States, the annual incidence of pneumonia is 24.8 cases per 10,000 adults, with higher rates as age increases.

Oscillating Positive Expiratory Pressure Devices Market Competitor Analysis

The global OPEP devices market is competitive and consists of very few major players. The competitive landscape includes an analysis of a few international as well as local companies which hold considerable market shares and are well-known, including AirPhysio, D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, and Smiths Medical, Inc. among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic Respiratory Diseases Across the Globe
    • 4.2.2 Growing Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product Type
    • 5.1.1 Face Mask PEP Devices
    • 5.1.2 Mouthpiece PEP Devices
    • 5.1.3 Bottle PEP Devices
  • 5.2 By Indication
    • 5.2.1 COPD and Asthma
    • 5.2.2 Bronchitis
    • 5.2.3 Cystic Fibrosis
    • 5.2.4 Others
  • 5.3 By End-User
    • 5.3.1 Hospital and Clinics
    • 5.3.2 Ambulatory Surgical Centers
    • 5.3.3 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World (ROW)

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AirPhysio
    • 6.1.2 Smiths Medical
    • 6.1.3 D-R Burton Healthcare
    • 6.1.4 Medica Holdings, LLC
    • 6.1.5 Monaghan Medical Corporation
    • 6.1.6 PARI GmbH
    • 6.1.7 R. Cegla GmbH & Co. KG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS